Stepwise strategies to successfully recruit diabetes patients in a large research study in Mexican population

Wacher, Niels H.; Reyes-Sánchez, Mario; Vargas-Sánchez, Héctor Raúl; Gamiochipi-Cano, Mireya; Rascón-Pacheco, Ramón Alberto; Gómez-Díaz, Rita A.; Doubova, Svetlana Vladislavovna; Valladares‐Salgado, Adán; Sánchez-Becerra, Martha Catalina; Méndez-Padrón, Araceli; Valdez-González, Leticia A; Mondragón-González, Rafael; Cruz, Miguel; Salinas-Martı́nez, Ana Marı́a; Garza-Sagástegui, María Guadalupe; Hernández-Rubí, Jaime; González-Hermosillo, Arturo; Borja-Aburto, Víctor Hugo

doi:10.1016/j.pcd.2017.02.005

Cited by 7 publications

(4 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Another limitation is related to the fact that prevalence data were obtained by reviewing medical records, as pointed out in a previous study. 36 It should be noted that the assignment of ICD-10 codes is made by the doctor who grants medical appointment, depending on the reasons he or she believes motivated the visit, which is quite limited in time and it is possible that not all complications or comorbidities of the patient are recorded. In addition, since complications are recorded in ICD-10 codes, it is impossible to subdivide them into clinical stages or subgroups.…”

Section: )* N/a N/a N/a N/a N/a N/a N/a N/a N/amentioning

confidence: 99%

Prevalence of diabetes complications and associated comorbidities in the Family Medicine setting at the Mexican Institute of Social Security

Ovalle-Luna¹,

Jiménez-Martínez²,

Rascón-Pacheco³

et al. 2023

GMM

Self Cite

View full text Add to dashboard Cite

Introduction:The prevalence of chronic complications and comorbidities in patients with type 2 diabetes (T2D) has increased worldwide. Objective: To compare the prevalence of complications and chronic comorbidities in patients with T2D at 36 family medicine units of five chapters of the Mexican Institute of Social Security (IMSS). Method: Complications (hypoglycemia, diabetic foot, kidney disease, retinopathy, ischemic heart disease, cerebrovascular disease and heart failure) and comorbidities (liver disease, cancer and anemia) were identified according to codes of the International Classification of Diseases, 10th Revision. Comparisons were made by chapter, age, and gender and evolution time. Results: Complications and comorbidities were more common in subjects aged ≥ 62 years. Out of 297 100 patients, 31.8% had any complication or comorbidity; microvascular complications (32 %) prevailed in the industrial North, whereas macrovascular complications (12.3 %) did in the rural East, and comorbidities (5 %) in southern Mexico City. Complications predominated in men (any complication, 30.2 %). Heart failure and comorbidities were more common in women (5.6 % and 4.9 %, respectively). Conclusions: T2D complications and comorbidities showed geographic and gender differences, and were greater with older age and longer evolution time. It is urgent for strategies for the prevention of complications and comorbidities to be reinforced in patients with T2D.

show abstract

Section: )* N/a N/a N/a N/a N/a N/a N/a N/a N/amentioning

confidence: 99%

Prevalence of diabetes complications and associated comorbidities in the Family Medicine setting at the Mexican Institute of Social Security

Ovalle-Luna¹,

Jiménez-Martínez²,

Rascón-Pacheco³

et al. 2023

GMM

Self Cite

View full text Add to dashboard Cite

show abstract

“…The eligible participants can be contacted directly as their contact details are available on Bru-HIMS and BruHealth. Contacting by phone can be a tedious, costly and timeconsuming process, and does not guarantee a good response rate (48)(49)(50)(51). Although emails are convenient and cost-effective, response rates are poor as they are usually ignored (52).…”

Section: Recruitment By Smsmentioning

confidence: 99%

Technology-assisted adaptive recruitment strategy for a large nation-wide COVID-19 vaccine immunogenicity study in Brunei

Shim¹,

Chan²,

Wei³

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

A national study was conducted in Brunei to assess and compare the immunogenicity of the various brands of COVID-19 vaccines administered to the population as part of the National COVID-19 Vaccination Programme. Most of the population have had received at least 2 doses of BBIBP-CorV, AZD1222 or MRNA-1273 vaccines. Neutralising antibodies against SARS-CoV-2 induced by these vaccines will be analysed to infer population-level immune protection against COVID-19. During the 5-week recruitment period, 24,260 eligible individuals were invited to the study via SMS, out of which 2,712 participants were enrolled into the study. This paper describes the novel adaptive strategy used to recruit the study participants. Digital technology was leveraged to perform targeted online recruitment to circumvent the limitations of traditional recruitment methods. Technology also enabled stratified random selection of these eligible individuals who were stratified based on age, gender and vaccine brand. Data was extracted from the electronic health records, the national mobile health application and a third-party survey platform and integrated into a dedicated research platform called EVYDResearch. The instant availability and access to up-to-date data on EVYDResearch enabled the study team to meet weekly and adopt an adaptive recruitment strategy informed by behavioural science, where interventions could be quickly implemented to improve response rates. Some examples of these include incorporating nudge messaging into SMS invitations, involving the Minister of Health to make press announcements on this study, media coverage, setting up an enquiries hotline and reaching out to foreign language speaking expatriates of a local multinational company to participate in this study. Data integration from various data sources, real time information sharing and a strong teamwork led to good outcomes adaptable to the progress of recruitment, compared to the more time-consuming and static traditional recruitment methods.

show abstract

“…IMSS has demonstrated capacity to design and test diabetes innovations in the past and the CDPM follows in this trend [20,[34][35][36][37]. However, innovation efforts are mostly spearheaded and organized by upper management without the participation of sector-wide actors and strategies and of national and international research and innovation institutions.…”

Section: Constructmentioning

confidence: 99%

Diabetes care innovation in the Mexican Institute for Social Insurance: Scaling up the preventive chronic disease care model to address critical coverage constraints

González-Block

Díaz-Portillo²,

Morales

et al. 2021

Primary Care Diabetes

View full text Add to dashboard Cite

Stepwise strategies to successfully recruit diabetes patients in a large research study in Mexican population

Cited by 7 publications

References 49 publications

Prevalence of diabetes complications and associated comorbidities in the Family Medicine setting at the Mexican Institute of Social Security

Prevalence of diabetes complications and associated comorbidities in the Family Medicine setting at the Mexican Institute of Social Security

Technology-assisted adaptive recruitment strategy for a large nation-wide COVID-19 vaccine immunogenicity study in Brunei

Diabetes care innovation in the Mexican Institute for Social Insurance: Scaling up the preventive chronic disease care model to address critical coverage constraints

Contact Info

Product

Resources

About